Abu-Amero K K, Alzahrani A S, Zou M, Shi Y
Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Oncogene. 2006 Feb 2;25(5):677-84. doi: 10.1038/sj.onc.1209094.
Medullary thyroid carcinoma (MTC) is a malignant tumour of the calcitonin-secreting parafollicular C cells of the thyroid, and occurs sporadically or as a component of the multiple endocrine neoplasia (MEN) type 2/familial medullary thyroid carcinoma (FMTC) syndromes. In the present study, we investigated the frequency of mtDNA mutations in 26 MTC tumour specimens (13 sporadic and 13 familial MTC) and their matched normal tissues by sequencing the entire coding regions of mitochondrial genome. Nonsynonymous mutations were detected in 20 MTC samples (76.9%): nine out of 13 sporadic MTC (69.2%) and 11 out of 13 (84.6%) familial MTC/MEN2. Both transition and transversion types of mutations were found in the samples. Interestingly, 76.2% (16/21) of transversion mutations were found in FMTC/MEN2 patients, whereas 66.7% (12/18) of transition mutations were in sporadic MTC. Synonymous mutations were found in 12 MTC samples. In total, we identified 27 transversion mutations (21 nonsynonymous and six synonymous) in MTC. Of them, 22 (81.5%) were from FMTC/MEN2, and five (18.5%) were from sporadic MTC. The association of transversion mutation with familial MTC/MEN2 was statistically significant (P = 0.0015, binomial test). Majority of the mutations were involved in the genes located in the complex I of the mitochondrial genome, and were often resulting in a change of a moderately or highly conserved amino acid of their corresponding protein. Mitochondrial respiratory function was also compromised in a TT cell line, which carries mtDNA mutation at nt 4917 and 11,720, and in peripheral lymphocytes of MTC patients with mtDNA mutations. These data suggest that mtDNA mutation may be involved in MTC tumourigenesis and progression. Given that mtDNA mutation spectra are different between sporadic and familial MTC, different mechanisms of oxidative DNA damage may occur in the disease process.
甲状腺髓样癌(MTC)是一种起源于甲状腺分泌降钙素的滤泡旁C细胞的恶性肿瘤,可散发性发生,或作为2型多发性内分泌腺瘤病(MEN)/家族性甲状腺髓样癌(FMTC)综合征的一部分出现。在本研究中,我们通过对线粒体基因组的整个编码区域进行测序,调查了26例MTC肿瘤标本(13例散发性和13例家族性MTC)及其匹配的正常组织中线粒体DNA(mtDNA)突变的频率。在20例MTC样本(76.9%)中检测到非同义突变:13例散发性MTC中有9例(69.2%),13例家族性MTC/MEN2中有11例(84.6%)。在样本中发现了转换和颠换两种类型的突变。有趣的是,76.2%(16/21)的颠换突变见于FMTC/MEN2患者,而66.7%(12/18)的转换突变见于散发性MTC。在12例MTC样本中发现了同义突变。我们总共在MTC中鉴定出27个颠换突变(21个非同义突变和6个同义突变)。其中,22个(81.5%)来自FMTC/MEN2,5个(18.5%)来自散发性MTC。颠换突变与家族性MTC/MEN2的关联具有统计学意义(二项式检验,P = 0.0015)。大多数突变涉及线粒体基因组复合体I中的基因,并且常常导致其相应蛋白质的一个中度或高度保守氨基酸发生改变。携带nt 4917和11720处mtDNA突变的TT细胞系以及具有mtDNA突变的MTC患者的外周淋巴细胞中的线粒体呼吸功能也受到损害。这些数据表明,mtDNA突变可能参与了MTC的肿瘤发生和进展。鉴于散发性和家族性MTC的mtDNA突变谱不同,在疾病过程中可能发生不同的氧化性DNA损伤机制。